This study opens the way to other perspectives (1) an in depth molecular and metabolomic exploration of synergistic action of the CRA-CGA couple on insulin secretion, insulin sensitivity and antioxidant signaling pathways and (2) by a clinical trial on METS patients with obesity and elevated risk of cardiovascular disease. The gene discussed is INS; the disease is cardiovascular disorder.